SCOPUS 정보 검색 플랫폼

New England Journal of Medicine

Volumn 366, Issue 7, 2012, Pages 668-669

The human plasma lipidome

(2) Ortiz, Alberto a Sanchez Ninõ, Maria D b

a HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ (Spain)

b HOSPITAL UNIVERSITARIO LA PAZ (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBOTRIAOSYSPHINGOSINE; GLYCOLIPID; LIPID; LIPIDOME; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

CELL DAMAGE; CELL PROLIFERATION; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; FABRY DISEASE; GAUCHER DISEASE; HUMAN; LETTER; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID STORAGE; PATIENT MONITORING; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TARGET CELL;

EID: 84857127783 PISSN: 00284793 EISSN: 15334406 Source Type: Journal
DOI: 10.1056/NEJMc1114201 Document Type: Letter

Times cited : (7)

References (6)

1
- 80955141082
- The human plasma lipidome
- Quehenberger O, Dennis EA. The human plasma lipidome. N Engl J Med 2011;365:1812-23.
- (2011) N Engl J Med , vol.365 , pp. 1812-1823
- Quehenberger, O.¹ Dennis, E.A.²

2
- 42949119819
- Elevated globotriaosylsphingosine is a hallmark of Fabry disease
- DOI 10.1073/pnas.0712309105
- Aerts JM, Groener JE, Kuiper S, et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci U S A 2008;105:2812-7. (Pubitemid 351723626)
- (2008) Proceedings of the National Academy of Sciences of the United States of America , vol.105 , Issue.8 , pp. 2812-2817
- Aerts, J.M.¹ Groener, J.E.² Kuiper, S.³ Donker-Koopman, W.E.⁴ Strijland, A.⁵ Ottenhoff, R.⁶ Van Roomen, C.⁷ Mirzaian, M.⁸ Wijburg, F.A.⁹ Linthorst, G.E.¹⁰ Vedder, A.C.¹¹ Rombach, S.M.¹² Cox-Brinkman, J.¹³ Somerharju, P.¹⁴ Boot, R.G.¹⁵ Hollak, C.E.¹⁶ Brady, R.O.¹⁷ Poorthuis, B.J.¹⁸

3
- 77954959657
- Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry disease
- Rombach SM, Dekker N, Bouwman MG, et al. Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. Biochim Biophys Acta 2010;1802:741-8.
- (2010) Biochim Biophys Acta , vol.1802 , pp. 741-748
- Rombach, S.M.¹ Dekker, N.² Bouwman, M.G.³

4
- 78650275925
- Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy
- van Breemen MJ, Rombach SM, Dekker N, et al. Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy. Biochim Biophys Acta 2011;1812:70-6.
- (2011) Biochim Biophys Acta , vol.1812 , pp. 70-76
- Van Breemen, M.J.¹ Rombach, S.M.² Dekker, N.³

5
- 77956264231
- Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease
- Togawa T, Kawashima I, Kodama T, et al. Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease. Biochem Biophys Res Commun 2010;399:716-20.
- (2010) Biochem Biophys Res Commun , vol.399 , pp. 716-720
- Togawa, T.¹ Kawashima, I.² Kodama, T.³

6
- 79958165587
- Globotriaosylsphingosine actions on human glomerular podocytes: Implications for Fabry nephropathy
- Sanchez-Niño MD, Sanz AB, Carrasco S, et al. Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy. Nephrol Dial Transplant 2011;26:1797-802.
- (2011) Nephrol Dial Transplant , vol.26 , pp. 1797-1802
- Sanchez-Niño, M.D.¹ Sanz, A.B.² Carrasco, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.